Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Patient received first dose of Shingrix less than 0.5 ml; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 07-OCT-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced accidental underdose (Verbatim: Patient received first dose of Shingrix less than 0.5 ml). The outcome of the accidental underdose was not applicable. Additional Information: GSK receipt date: 08-OCT-2025 Pharmacist reported that a male patient received less than 0.5 ml dose of Shingrix on 10-JUL-2025 which was due a syringe issue. No PQC reported.